Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Luke Combs on Skipping GLP-1s for Weight Loss: 'Not the Short Way' - Featured image
Weight Loss

Luke Combs on Skipping GLP-1s for Weight Loss: 'Not the Short Way'

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·February 25, 2026·6 min read

On this page

  • Luke Combs Opens Up About His Biggest Fears
  • Lifelong Weight Struggles and the Appeal of the 'Hard Way'
  • Family Motivation Drives Longevity Goals
  • Understanding GLP-1 Medications: Why They're Popular for Weight Loss
  • GLP-1s vs. Lifestyle Changes: Comparing Approaches
  • Safety Considerations for GLP-1 Use
  • Practical Guidance: Should You Consider GLP-1s or Go the 'Luke Combs Way'?
  • Key Takeaways: What Luke Combs' Story Means for Metabolic Health
  • Conclusion: Your Path to Health
  • How GLP-1s Work in the Body
  • Pros of GLP-1 Medications
  • Cons and Combs' Concerns

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

Grammy-nominated country singer Luke Combs revealed on The New York Times' Popcast why GLP-1 weight loss drugs aren't for him: he wants to 'beat myself' the hard way. Motivated by his wife and kids, Combs embraces the struggle over quick fixes amid lifelong weight battles. His story highlights the personal choice in pursuing metabolic health.

Share

On this page

  • Luke Combs Opens Up About His Biggest Fears
  • Lifelong Weight Struggles and the Appeal of the 'Hard Way'
  • Family Motivation Drives Longevity Goals
  • Understanding GLP-1 Medications: Why They're Popular for Weight Loss
  • GLP-1s vs. Lifestyle Changes: Comparing Approaches
  • Safety Considerations for GLP-1 Use
  • Practical Guidance: Should You Consider GLP-1s or Go the 'Luke Combs Way'?
  • Key Takeaways: What Luke Combs' Story Means for Metabolic Health
  • Conclusion: Your Path to Health
  • How GLP-1s Work in the Body
  • Pros of GLP-1 Medications
  • Cons and Combs' Concerns

Luke Combs on Skipping GLP-1s for Weight Loss: 'Not the Short Way'

In a candid discussion on GLP-1 medications for weight loss, Grammy-nominated country singer Luke Combs shared his reasons for steering clear of these popular drugs. During the Tuesday, Feb. 24, episode of The New York Times' Popcast podcast, the 35-year-old "Back in the Saddle" singer and father of three emphasized his commitment to tackling health challenges through effort rather than medical shortcuts.

Luke Combs Opens Up About His Biggest Fears

Combs got real about one of his "biggest fears": "One of my biggest fears is like, man, maybe I don't get a shot just 'cause of the way I look," he said. "You know what I mean? And like, that was a hard pill to swallow, because you can't really change the way you look."

As his fame grew, Combs noted he hasn't faced pressure from music industry executives to alter his appearance, such as hiring a trainer or changing his beard. He even joked about dreaming of looking like fellow country star Sam Hunt "everyday."

Lifelong Weight Struggles and the Appeal of the 'Hard Way'

"I have always struggled with my weight," Combs admitted. "It bugs me a lot that I can't figure it out. I don't want my life to be this life of like, ease and like, everything's easy. I like when stuff's hard."

When asked about avoiding "medical technology" like GLP-1 medications—such as semaglutide brands including Ozempic and Wegovy—Combs agreed. "As dumb as that sounds, that stuff scares me more than I think that I would enjoy the benefits of," he said.

Combs confessed he's never faced truly hard physical labor: "Like, I'm not out digging ditches, man. It's not that hard of a job." Yet his body image issues persist as "this thing I can't conquer." "No matter how hard I try, it's just been like this impossible nut to crack for me. And I will do it, but I'm not going to do it the short way," he declared. "And not that there's anything wrong with that. That's personal for you. I need to win, like, I need to beat myself."

Family Motivation Drives Longevity Goals

Combs has consistently shared his health motivations tied to family. In June 2022, he told Zane Lowe on Apple Music 1 about his son Tex Lawrence, born that month with wife Nicole Hocking: "This having a kid thing has really messed up my head on this thing in the best way. I want to be around, dude. Do you know what I mean?"

More recently, in November 2024, he told NBC News that "longevity is the goal" thanks to his wife and kids. "Every day you get to spend with those guys is really fun and tough, and you need to be your best self to take care of them the way that you feel like they deserve to be taken care of."

"It's a long process, man. It's a long road," Combs added. "It's tough. It's a challenge, man. I struggle with it every day."

Understanding GLP-1 Medications: Why They're Popular for Weight Loss

GLP-1 receptor agonists, like semaglutide (found in Ozempic and Wegovy) and tirzepatide (in Mounjaro and Zepbound), mimic the glucagon-like peptide-1 hormone. This hormone regulates blood sugar, slows gastric emptying, and signals fullness to the brain, leading to reduced appetite and significant weight loss—often 15-20% of body weight in clinical trials.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

These medications were originally developed for type 2 diabetes but gained fame for obesity treatment after studies like STEP and SURMOUNT showed sustained results. For many, they address metabolic health issues tied to insulin resistance, cardiovascular risk, and inflammation. However, Combs' perspective underscores a common concern: reliance on pharmacology versus building sustainable habits.

How GLP-1s Work in the Body

  • Appetite Suppression: Activates brain receptors to reduce hunger.
  • Delayed Digestion: Slows stomach emptying for prolonged satiety.
  • Blood Sugar Control: Boosts insulin release and lowers glucagon.

While effective, they require weekly injections and lifestyle support for optimal outcomes.

GLP-1s vs. Lifestyle Changes: Comparing Approaches

Pros of GLP-1 Medications

  • Rapid, clinically proven weight loss.
  • Benefits for comorbidities like heart disease and sleep apnea.
  • Bridge for those with metabolic barriers to diet/exercise alone.

Cons and Combs' Concerns

  • Potential side effects: nausea, gastrointestinal issues, muscle loss if not paired with exercise.
  • Cost and access barriers (often $1,000+/month without insurance).
  • Weight regain upon discontinuation without habit changes.
  • Psychological aspects: Combs fears missing the "win" of self-conquest.

Combs' choice aligns with evidence that lifestyle interventions—calorie control, strength training, and cardio—yield 5-10% weight loss long-term for motivated individuals, fostering discipline like he seeks.

Safety Considerations for GLP-1 Use

Common side effects include nausea (up to 44% in trials), vomiting, and diarrhea, often improving over time. Rare risks: pancreatitis, gallbladder issues, thyroid tumors (in rodents). Not recommended for those with medullary thyroid cancer history or multiple endocrine neoplasia syndrome type 2.

Monitoring is key; tools like Shotlee can help users track symptoms, side effects, or medication schedules alongside diet logs.

Practical Guidance: Should You Consider GLP-1s or Go the 'Luke Combs Way'?

Who Might Benefit from GLP-1s:

  • BMI ≥30 (or ≥27 with conditions like hypertension).
  • Failed prior weight loss attempts.
  • Need for cardiometabolic improvements.

Opting for Natural Methods Like Combs:

  • Motivated by personal challenge and family.
  • Prefer building habits: 150+ min/week exercise, protein-rich diet, sleep optimization.
  • Track progress with apps for accountability.

Discuss with a doctor: GLP-1s aren't for cosmetic use alone. Combine approaches for best results—many use meds as a kickstart while adopting Combs' mindset for maintenance.

Key Takeaways: What Luke Combs' Story Means for Metabolic Health

  • GLP-1s offer powerful tools but aren't one-size-fits-all.
  • Personal motivation trumps shortcuts for sustainable change.
  • Family and longevity goals fuel lasting commitment.
  • Weight struggles are common; conquering them builds resilience.

Conclusion: Your Path to Health

Luke Combs' rejection of GLP-1s highlights the value of effort-driven weight management in metabolic health. Whether choosing medications or the hard road, prioritize doctor-guided plans. His story reminds us: health is personal—embrace what aligns with your values for long-term success.

Read the original article on People for more celebrity insights.

Source Information

Originally published by Yahoo.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

New Weight Loss Pill Beats Oral Ozempic in Major Clinical Trial
Medication News

New Weight Loss Pill Beats Oral Ozempic in Major Clinical Trial

A recent Phase 3 clinical trial indicates that orforglipron offers superior blood sugar control and weight loss compared to oral semaglutide, though side effects remain a consideration.

9 min read
Bariatric Surgery Shows 5x More Weight Loss Than GLP-1s in Real-World Study
Weight Management

Bariatric Surgery Shows 5x More Weight Loss Than GLP-1s in Real-World Study

A groundbreaking real-world comparison study presented at the ASMBS 2025 Annual Scientific Meeting found that bariatric surgery resulted in approximately five times more weight loss compared to popular GLP-1 receptor agonist medications over a two-year period. This research highlights important considerations for patients and healthcare providers navigating weight management options.

7 min read
Mounjaro's Impact on Food Cravings: A Case Study
Medical Research

Mounjaro's Impact on Food Cravings: A Case Study

A groundbreaking case study involving deep brain activity recordings has shed light on how tirzepatide, known as Mounjaro and Zepbound, impacts the brain's reward center and its connection to food cravings and loss of control eating.

8 min read

Same topic: GLP-1 Agonists

All GLP-1 Agonists articles →
The Next Ozempic: A 4-in-1 Breakthrough for Lasting Weight Loss
Medical Research

The Next Ozempic: A 4-in-1 Breakthrough for Lasting Weight Loss

While Ozempic and similar GLP-1 agonists have revolutionized weight management, new research from Tufts University is exploring a novel 4-in-1 peptide that targets four hormone receptors for potentially greater efficacy and fewer side effects, moving closer to the gold standard of bariatric surgery.

6 min read
Most People Who Stop GLP-1 Drugs Like Ozempic Eventually Restart Treatment
Diabetes Management

Most People Who Stop GLP-1 Drugs Like Ozempic Eventually Restart Treatment

A recent study presented at ENDO 2026 sheds light on the patterns of GLP-1 medication use for type 2 diabetes, revealing that while many patients stop treatment, a substantial number later restart, suggesting a more cyclical rather than permanent discontinuation.

7 min read
Ozempic and Wegovy Linked to Reduced Violent Behavior in New Study
Health & Wellness

Ozempic and Wegovy Linked to Reduced Violent Behavior in New Study

Beyond their well-known benefits for weight loss and diabetes management, popular GLP-1 medications such as Ozempic and Wegovy are now being studied for their potential impact on violent behavior. Emerging research from Rutgers University indicates a surprising link between these drugs and a reduction in actions associated with violence.

6 min read

More in Weight Loss

GLP-1 Breakthrough: Mazdutide Outperforms Semaglutide for Weight Loss & Diabetes
Weight Loss

GLP-1 Breakthrough: Mazdutide Outperforms Semaglutide for Weight Loss & Diabetes

New research shows that Mazdutide may be superior to Semaglutide (Ozempic/Wegovy) for weight loss and improved blood sugar control. Learn about this exciting development and what it means for the future of diabetes and weight management.

3 min read
GLP-1s & Hollywood: Decoding Clooney's Weight Loss Transformation
Weight Loss

GLP-1s & Hollywood: Decoding Clooney's Weight Loss Transformation

George Clooney's recent appearance sparked concerns about his health, with many attributing his weight loss to GLP-1 drugs like Ozempic. This raises important questions about the use of these medications and their impact on overall wellness and longevity.

3 min read
Whoopi Goldberg's Health Journey: Weight Loss, Sciatica & Hollywood Pressure
Weight Loss

Whoopi Goldberg's Health Journey: Weight Loss, Sciatica & Hollywood Pressure

Whoopi Goldberg's recent weight loss has sparked conversations about her health, including her struggles with sciatica and the pressures of Hollywood. This article explores her journey and the challenges faced by aging women in the entertainment industry.

3 min read
Share this article
  1. Home
  2. Blog
  3. Luke Combs on Skipping GLP-1s for Weight Loss: 'Not the Short Way'
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community